Home - Translational Lung Cancer Research

Interviews with Editorial Board Members

TLCR features a distinguished editorial board, the members of which continue to instill the power of their expertise for the journal’s development. By launching this column, we are glad to introduce to you some of them in the form of interviews, in which they will share their unique career experiences and perspectives. We believe their insights will shed light on the knowledge of related fields.

Interviews with Guest Editors

Over the years, a number of TLCR guest editors have made valuable contributions to the journal. This column features interviews with our guest editors, who graciously share their experience in scientific careers and provide insightful perspectives on the special series.

New Impact Factor for Translational Lung Cancer Research: 4

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has attained its latest impact factor update for the 2023 citation year: 4.

Translational Lung Cancer Research 2023 CiteScore Released: 7.2

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has received its 2023 CiteScore: 7.2, ranking 92 out of 404 journals in the Oncology category.

Furthermore, we are delighted to highlight the remarkable achievements made by all AME journals in the CiteScore ranking.

Interviews with Outstanding Authors (2024)

In 2024, many authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.

Hereby, we would like to highlight some of our outstanding authors, with a brief interview of their thoughts and insights as authors. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Reviewer of the Month (2024)

In 2024, TLCR reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

TLCR Annual Report 2023

Welcome to the 2023 annual report for Translational Lung Cancer Research. In 2023, the TLCR has continued its mission to increase the quality and impact of the journal, and to provide readers with a novel, well-organized, informative, enlightening and educational journal.

We would like to sincerely thank our Editorial Board Members, Guest editors, Reviewers, Authors, Readers for all your supports and contributions to TLCR in 2023, and we look forward to continuing our work with you in the new year.

‹ ›

Vol 13, No 11 (November, 2024)

Articles in Press

Past Issues

About tlcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

General editorial enquiries:
Email: editor@tlcr.org
Copyright related contact:
Email: permissions@amegroups.com
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com

Editorial Commentary

Epidermal growth factor receptor exon 20 insertion mutations: are we getting closer to solving the puzzle?

Thomas E. Stinchcombe

PDF Pages: 2864-2867 Full Text (155) Peer Review File COI Form Open Access

Original Article

Lung autotransplantation for advanced central lung cancer after neoadjuvant immuno-chemotherapy: a case series study

Yongjiang Chen, Rui Wang, Dong Lin, Hui Pan, Chao Yang, Hongxu Liu, Wei Huang, Jiang Fan, Shuben Li

PDF Pages: 2868-2879 Full Text (360) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

The potential high-risk population for lung cancer screening: determination of initial screening age and heterogeneity in histology and sex

Keyi Chen, Yanze Yin, Chao Wang, Ao Zeng, Xinyun Fang, Abudumijiti Abuduwayiti, Zhilong Xu, Jie Dai, Gening Jiang

PDF Pages: 2880-2889 Full Text (220) Reporting Checklist Peer Review File COI Form Open Access

Comparing the outcomes of MR-based versus CT-based tumor delineation in locally advanced non-small cell lung cancer treated with hypo-fractionated radiotherapy and concurrent chemotherapy

Pengxin Zhang, Shouliang Ding, Kangqiang Peng, Haoqiang He, Daquan Wang, Rui Zhou, Bin Wang, Jinyu Guo, Hongdong Liu, Xiaoyan Huang, Chuanmiao Xie, Hui Liu, Bo Qiu

PDF Pages: 2890-2902 Full Text (198) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Altered carnitine transporter genes (SLC22A5, SLC22A16, SLC6A14) expression pattern among lung cancer patients

Konrad Kędzia, Dagmara Szmajda-Krygier, Adrian Krygier, Sławomir Jabłoński, Ewa Balcerczak, Szymon Wcisło

PDF Pages: 2903-2917 Full Text (179) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Treatment of metastatic ALK-positive non-small cell lung cancer: real-world outcomes in a single center study

Caroline Kamali, Georgios Tsakonas, Per Hydbring, Kenbugul Jatta, Anders Berglund, Kristina Viktorsson, Rolf Lewensohn, Luigi De Petris, Simon Ekman

PDF Pages: 2918-2933 Full Text (367) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Optimizing epidermal growth factor receptor-tyrosine kinase inhibitor treatment in lung cancer: a systematic review and meta-analysis of the influence of gastric acid suppressants

Beong Ki Kim, Ye Seul Seong, Se Hyun Kwak, Eun Hye Lee, Sang Hoon Lee, Eun Young Kim, Yoon Soo Chang, Chi Young Kim

PDF Pages: 2934-2946 Full Text (240) Reporting Checklist Peer Review File COI Form Open Access

Three-dimensional reconstruction for determining positional indications of pulmonary segmentectomy/subsegmentectomy for ground glass opacity-dominant clinical T1a-bN0 non-small cell lung cancer

Chengyu Bian, Chenghao Fu, Wentao Xue, Yan Gu, Hongchang Wang, Wenhao Zhang, Guang Mu, Mei Yuan, Liang Chen, Jingjing Huang, Qianyun Wang, Jun Wang

PDF Pages: 2947-2957 Full Text (210) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Construction and validation of deep learning model for cachexia in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors: a multicenter study

Ruiting Song, Butuo Li, Xiaoqing Wang, Xinyu Fan, Zhonghang Zheng, Yawen Zheng, Junyi He, Chunni Wang, Linlin Wang

PDF Pages: 2958-2971 Full Text (244) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Predictive value of longitudinal systemic inflammatory markers for pathologic response to neoadjuvant PD-1 blockade in resectable non-small cell lung cancer

Xiuli Tao, Qian Zhang, Pei Yuan, Shuhang Wang, Jianming Ying, Ning Li, Wei Guo, Jing Li, Lei Guo, Ying Liu, Zewei Zhang, Shijun Zhao, Shugeng Gao, Ning Wu

PDF Pages: 2972-2986 Full Text (337) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Characterization of the BH1406 non-small cell lung cancer (NSCLC) cell line carrying an activating SOS1 mutation

Gerhard Hamilton, Sandra Stickler, Mikhail Ermakov, Marie-Therese Eggerstorfer, Francesca Paola Nocera, Martin Hohenegger, Lukas Weigl, Maximilian Johannes Hochmair, Karl Kashofer

PDF Pages: 2987-2997 Full Text (303) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Phase Ib/II study of imprime PGG and pembrolizumab in patients with previously treated advanced non-small cell lung cancer (NSCLC): BTCRC LUN 15-017

Muhammad Furqan, Jyoti Malhotra, Ardaman Shergill, Li Liu, Sarah L. Mott, Mary M. Pasquinelli, Alicia Hulbert, Kathleen Kennedy, Lawrence Feldman

PDF Pages: 2998-3009 Full Text (249) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

STING facilitates the development of radiation-induced lung injury via regulating the PERK/eIF2α pathway

Xiangwei Ge, Qiaowei Liu, Hao Fan, Hongyang Yu, Jinfeng Li, Yao Li, Boyu Qin, Junxun Ma, Jinliang Wang, Yi Hu

PDF Pages: 3010-3025 Full Text (240) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Mutational differences between primary cancer tissue and circulating tumor cells in early-stage non-small cell lung cancer

Woojung Kim, Sukki Cho, Joonseok Lee, Jinsu Lee, Soojeong Ji, Hyejin Sung, Woohyun Jung, Jae Hyun Jeon, Kwhanmien Kim, Sanghoon Jheon

PDF Pages: 3026-3038 Full Text (182) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Analysis of the lymph node metastasis distribution in patients with invasive resectable non-small cell lung cancer

Congcong Xu, Jiajing Sun, Hao Liu, Baofu Chen, Sikai Wu, Hongbin Qiu, Jiawei Li, Dong Chen, Kanghao Zhu, Zixian Jin, Jian Zhang, Bo Zhang, Zhongxiao Chen, Pasan Witharana, William C. Cho, Jianfei Shen

PDF Pages: 3039-3049 Full Text (254) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Treatment patterns and clinical outcomes of resectable central non-small cell lung cancer patients undergoing sleeve lobectomy: a large-scale, single-center, real-world study

Rui Han, Fan Zhang, Chang Zhan, Qian Hong, Chenguang Zhao, Visar Djaferi, Fuquan Wang, Pengfei Qi, Shan Muhammad, Fang Li, Jiagen Li, Juwei Mu

PDF Pages: 3050-3066 Full Text (Video) (222) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer

Nanao Terada, Hayato Koba, Shigeki Nanjo, Hideharu Kimura, Akihiro Nishiyama, Taro Yoneda, Takayuki Takeda, Hiroki Shirasaki, Koichi Nishi, Takashi Sone, Tadaaki Yamada, Koichi Takayama, Kazuhiko Shibata, Hiroki Matsuoka, Toshiyuki Kita, Kazuhiro Nagata, Yuichi Tambo, Noriyuki Ohkura, Johsuke Hara, Kazuo Kasahara, Shinji Kohsaka, Hiroyuki Mano, Seiji Yano

PDF Pages: 3067-3082 Full Text (379) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Evaluation of the ASPYRE-Lung targeted variant panel: a rapid, low-input solution for non-small cell lung cancer biomarker testing and experience from three independent sites

Sarah E. Herlihy, Caren Gentile, Samantha J. Scott, Brandon A. Smith, Kathryn A. Stoll, Kala F. Schilter, Justyna M. Mordaka, Rebecca N. Palmer, Christina Xyrafaki, Elizabeth Gillon-Zhang, Candace King, Ryan T. Evans, Amanda S. Green, Ana-Luisa Silva, Magdalena Stolarek-Januszkiewicz, Kristine von Bargen, Iyelola Turner, Chau Ha Ho, Alejandra Collazos, Nicola D. Potts, Dilyara Nugent, Jinsy Jose, Eleanor R. Gray, Elyse Shapiro, Wendy J. Levin, Aishling Cooke, Barnaby W. Balmforth, Robert J. Osborne, Honey V. Reddi, Vivianna M. Van Deerlin

PDF Pages: 3083-3095 Full Text (343) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Prognostic impact of targetable driver alterations in resected early-stage lung cancer

Angelika Terbuch, Selma Konjic, Verena Schlintl, Gudrun Absenger, Philipp J. Jost, Jörg Lindenmann, Paul Swatek, Nikolaus John, Teresa John, Robert Wurm, Martin Zacharias, Florian Posch, Maximilian J. Hochmair, Hannah Fabikan, Christoph Weinlinger, Oliver Illini, Lena Horvath, Gabriele Gamerith, Dominik Wolf, Florian Augustin, Luka Brcic

PDF Pages: 3096-3105 Full Text (258) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Association of baseline plasma D-dimer and platelets with progression-free survival in patients with stage IV non-small cell lung cancer treated with anti-PD-1 antibody

Boyue Pang, Jing Wang, Jing Wang, Jiali Zhang, Xiubao Ren, Ying Han

PDF Pages: 3106-3121 Full Text (237) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Circulating tumor cells are associated with lung cancer subtypes: a large-scale retrospective study

Lei Zhu, Erji Gao, Yusuke Tomita, An Li, Bo Tao

PDF Pages: 3122-3138 Full Text (215) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Construction of a risk prediction model for isolated pulmonary nodules 5–15 mm in diameter

Siting Xie, Xingguang Luo, Yuxin Guo, Xiulian Huang, Jinyu Long, Ying Chen, Ping Lin, Jinhe Xu, Shangwen Xu, Chunlei Zhao, Baoquan Lin, Chunxia Su, Nagarashee Seetharamu, Duilio Divisi, Mingliang Jin, Zongyang Yu

PDF Pages: 3139-3151 Full Text (164) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Construction and validation of a prognostic model based on oxidative stress-related genes in non-small cell lung cancer (NSCLC): predicting patient outcomes and therapy responses

Dongfeng Sun, Jie Lu, Wenhua Zhao, Xiaozheng Chen, Changyan Xiao, Feng Hua, Per Hydbring, Esteban C. Gabazza, Alfredo Tartarone, Xiaoming Zhao, Wenfeng Yang

PDF Pages: 3152-3174 Full Text (347) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Fluorofenidone enhances cisplatin efficacy in non-small cell lung cancer: a novel approach to inhibiting cancer progression

Shunjun Wang, Guowei Liu, Laishun Yu, Chenzi Zhang, Fabrizio Marcucci, Yupeng Jiang

PDF Pages: 3175-3188 Full Text (289) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Lower respiratory tract microbiome is associated with checkpoint inhibitor pneumonitis in lung cancer patients

Dongming Zhang, Junping Fan, Xiaoyan Liu, Xiaoxing Gao, Qing Zhou, Jing Zhao, Yan Xu, Wei Zhong, In-Jae Oh, Minjiang Chen, Mengzhao Wang

PDF Pages: 3189-3201 Full Text (185) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Correlations between 14-gene RNA-level assay and clinical and molecular features in resectable non-squamous non-small cell lung cancer: a cross-sectional study

Zhicheng Huang, Ming Zhao, Bowen Li, Jianchao Xue, Yadong Wang, Daoyun Wang, Chao Guo, Yang Song, Haochen Li, Xiaoqing Yu, Xinyu Liu, Ruirui Li, Jian Cui, Zhe Feng, Lan Su, Ka Luk Fung, Heqing Xu Rachel, Kakeru Hisakane, Atocha Romero, Shanqing Li, Naixin Liang

PDF Pages: 3202-3213 Full Text (228) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Influence of pleural invasion on survival in pathologic T3–4N0M0 non-small cell lung cancer: a propensity score matching study based on the Surveillance, Epidemiology, and End Results database

Wenqiang Zhang, Ziming Wang, Luyu Huang, Lara Sarigul, Diego Gonzalez-Rivas, Harun Badakhshi, Zhuangshi Huang, Jens-C. Rueckert, Mahmoud Ismail

PDF Pages: 3214-3223 Full Text (206) Reporting Checklist Peer Review File COI Form Open Access

Review Article

EGFR exon 20 insertion mutation and MET exon 14 skipping mutation in non-small cell lung cancer: a scoping review in the Chinese population

Xiao-Rong Yang, Si-Min Zhong, Zhen-Yi Jin, Xīn Gào, Ying Wu, Qing Zhou, Yang-Qiu Li, Si-Yang Maggie Liu, Yi-Long Wu

PDF Pages: 3224-3240 Full Text (257) Reporting Checklist Peer Review File COI Form Open Access

The latest advances in liquid biopsy for lung cancer—a narrative review

Wei She, Yago Garitaonaindia, Yun Lin

PDF Pages: 3241-3251 Full Text (298) Reporting Checklist Peer Review File COI Form Open Access

Case Report

Invasive mucinous adenocarcinoma harbored MET exon 14 skipping mutation: case report

Atsushi Washioka, Hiroaki Akamatsu, Takeya Sugimoto, Daiki Kitahara, Takahiro Kaki, Eriko Murakami, Atsushi Hayata, Ryuta Iwamoto, Nobuyuki Yamamoto

PDF Pages: 3252-3255 Full Text (207) Reporting Checklist Peer Review File COI Form Open Access

Review Articles

Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

Yoshihisa Kobayashi, Tetsuya Mitsudomi

Published online: 22 October 2013

PDF Pages: 354-363 Full Text (337350) Open Access

Editorial Commentary

Ground glass nodules with 5 years’ stability can grow after 10-year follow-up: do genetic features determine the fate?

Yoshihisa Kobayashi, Tetsuya Mitsudomi

Published online: 31 December 2019

PDF Pages: S425-S427 Full Text (76490) Open Access

Review Article

Non-small cell lung cancer: current treatment and future advances

Cecilia Zappa, Shaker A. Mousa

Published online: 30 June 2016

PDF Pages: 288-300 Full Text (72715) Open Access

Review Articles

Irreversible EGFR-TKIs: dreaming perfection

Lorenza Landi, Federico Cappuzzo

Published online: 14 January 2013

PDF Pages: 40-49 Full Text (69487) Open Access

Review Article

Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology

Jian-Wei Gao, Stefania Rizzo, Li-Hong Ma, Xiang-Yu Qiu, Arne Warth, Nobuhiko Seki, Mizue Hasegawa, Jia-Wei Zou, Qian Li, Marco Femia, Tang-Feng Lv, Yong Song, written on behalf of the AME Lung Cancer Collaborative Group

Published online: 28 February 2017

PDF Pages: 68-75 Full Text (55235) Open Access

Review Article

Recurrence after surgery in patients with NSCLC

Hidetaka Uramoto, Fumihiro Tanaka

Published online: 28 August 2014

PDF Pages: 242-249 Full Text (44116) Open Access

Review Article

Lung cancer prediction using machine learning and advanced imaging techniques

Timor Kadir, Fergus Gleeson

Published online: 14 June 2018

PDF Pages: 304-312 Full Text (41612) Open Access

Review Article

Targeted therapy for non-small cell lung cancer: current standards and the promise of the future

Bryan A. Chan, Brett G.M. Hughes

Published online: 24 February 2015

PDF Pages: 36-54 Full Text (41470) Open Access

Review Article

The past, present and future of immunotherapy against tumor

Tao Jiang, Caicun Zhou

Published online: 24 June 2015

PDF Pages: 253-264 Full Text (39028) Open Access

Review Article

Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment

Tianli Zhang, Bing Wan, Yuan Zhao, Chuling Li, Hongbing Liu, Tangfeng Lv, Ping Zhan, Yong Song

Published online: 30 June 2019

PDF Pages: 302-316 Full Text (38905) Open Access

Review Article

Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights

Yoshihisa Kobayashi, Chiara Ambrogio, Tetsuya Mitsudomi

Published online: 28 August 2018

PDF Pages: 487-497 Full Text (34384) Chinese (3565) Open Access

Review Articles

KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach

Javier de Castro Carpeño, Cristóbal Belda-Iniesta

Published online: 03 April 2013

PDF Pages: 142-151 Full Text (32048) Open Access

Review Article

Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey

Jeffrey P. Gregg, Tianhong Li, Ken Y. Yoneda

Published online: 30 June 2019

PDF Pages: 286-301 Full Text (31080) Open Access

Review Article

The epidemiology of lung cancer

Patricia M. de Groot, Carol C. Wu, Brett W. Carter, Reginald F. Munden

Published online: 14 June 2018

PDF Pages: 220-233 Full Text (30943) Open Access

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha, Hyo Sup Shim

Published online: 11 October 2017

PDF Pages: 508-512 Full Text (30594) Open Access

Review Article

Lung cancer screening: nodule identification and characterization

Ioannis Vlahos, Konstantinos Stefanidis, Sarah Sheard, Arjun Nair, Charles Sayer, Joanne Moser

Published online: 14 June 2018

PDF Pages: 288-303 Full Text (29673) Open Access

Consensus

Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou)

Jianxing He, Hengrui Liang, Wei Wang, Andrey Akopov, Alberto Aiolfi, Keng-Leong Ang, Luca Bertolaccini, Kaican Cai, Qingdong Cao, Baojun Chen, Chang Chen, Chun Chen, Donglai Chen, Fengxia Chen, Jun Chen, Lei Chen, Mingwu Chen, Yongbing Chen, Zhuxing Chen, Chao Cheng, Dong Cui, Fei Cui, Tianyang Dai, Qinglong Dong, Paolo A. Ferrari, Raja M. Flores, Junke Fu, Soichiro Funaki, Marios E. Froudarakis, Xiangfeng Gan, Mingfei Geng, Jialong Guo, Qiang Guo, Yongtao Han, Jintao He, Kaiming He, Kyoji Hirai, Jian Hu, Shuqiao Hu, Jian Huang, Jun Huang, Wenfa Jiang, Kyung Soo Kim, Gabor Kiss, Fanyi Kong, Lan Lan, Xuefeng Leng, Bin Li, Gaofeng Li, Hecheng Li, Hefei Li, Heng Li, Jiwei Li, Xiaoqiang Li, Shuben Li, Yinfen Li, Zhuoyi Li, Yi Liang, Lixia Liang, Wenhua Liang, Yongde Liao, Wanli Lin, Xu Lin, Hongxu Liu, Hui Liu, Jixian Liu, Jun Liu, Xiang Liu, Zihao Liu, Xingzhao Lu, Qingquan Luo, Naiquan Mao, Qi Pan, Dazhi Pang, Jun Peng, Jun Peng, Eugenio Pompeo, Rulin Qian, Kun Qiao, Bassam Redwan, Zi Sang, Wenlong Shao, Jianfei Shen, Weiyu Shen, Sook-Whan Sung, Wenfang Tang, Tianhu Wang, Guangsuo Wang, Haitao Wang, Huien Wang, Jiyong Wang, Wen Wang, Yongyong Wang, Zhenyuan Wang, Li Wei, Wei Wei, Hao Wu, Jie Wu, Zhaohua Xia, Chenyang Xu, Enwu Xu, Hai Xu, Ning Xu, Quan Xu, Rongyu Xu, Shun Xu, Chaokun Yang, Hanyu Yang, Shengli Yang, Jun Yi, Guangjian Zhang, Hao Zhang, Jia Zhang, Man Zhang, Xiao Zhang, Yajie Zhang, Zhe Zhang, Zhifeng Zhang, Honglin Zhao, Jian Zhao, Xiaodong Zhao, Jianping Zhou, Yanran Zhou, Chengchu Zhu, Shaojin Zhu, Xinhai Zhu, Jian Cui, Yubo Yan, Ke-Neng Chen

Published online: 28 August 2021

PDF Pages: 3503-3519 Full Text (28928) COI Form Open Access

Review Articles

New TNM classification: achievements and hurdles

Peter Goldstraw

Published online: 17 August 2013

PDF Pages: 264-272 Full Text (28658) Open Access

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Published online: 19 April 2015

PDF Pages: 156-164 Full Text (27987) Open Access

Review Articles

Angiogenesis in cancer: anti-VEGF escape mechanisms

Gerald W. Prager, Marina Poettler, Matthias Unseld, Christoph C. Zielinski

Published online: 18 February 2012

PDF Pages: 14-25 Full Text (27849) Open Access

Full Most Read article list >>

Original Article

Prognostic value of Twist in lung cancer: systematic review and meta-analysis

Junli Zeng, Ping Zhan, Guannan Wu, Wen Yang, Wenjun Liang, Tangfeng Lv, Yong Song

BRAF mutations in non-small cell lung cancer

Peter P. Luk, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina Selinger, Trina Lum, Steven Kao, Sandra A. O’Toole, Wendy A. Cooper

The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer

Shu Wang, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina I. Selinger, Sandra A. O’Toole, Wendy A. Cooper

Itraconazole can inhibit malignant pleural effusion by suppressing lymphangiogenesis in mice

Yunfen Wang, Yanwen Yao, Hongbin Liu, Xingqun Ma, Tangfeng Lv, Dongmei Yuan, Xinwu Xiao, Jie Yin, Yong Song

Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer

Fangfang Chen, Yanwen Yao, Chunyan Ma, Xingqun Ma, Zhaofeng Wang, Tangfeng Lv, Xinwu Xiao, Jie Yin, Yong Song

Advanced proton beam dosimetry part II: Monte Carlo vs. pencil beam-based planning for lung cancer

Dominic Maes, Jatinder Saini, Jing Zeng, Ramesh Rengan, Tony Wong, Stephen R. Bowen

The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants

Randa A. El-Zein, Carol J. Etzel, Reginald F. Munden

The use of TCP based EUD to rank and compare lung radiotherapy plans: in-silico study to evaluate the correlation between TCP with physical quality indices

Abdulhamid Chaikh, Jacques Balosso

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement

Hyojin Kim, Jin-Haeng Chung

Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer

Haoran Zhai, Wenzhao Zhong, Xuening Yang, Yi-Long Wu

Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations—a review

Erin L. Stewart, Samuel Zhixing Tan, Geoffrey Liu, Ming-Sound Tsao

Clinical trials for lung cancer in China

Fei-Yu Niu, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu

Recurrence after surgery in patients with NSCLC

Hidetaka Uramoto, Fumihiro Tanaka

Prognostic markers in lung cancer: is it ready for prime time?

Chang-Qi Zhu, Ming-Sound Tsao

Potential biomarkers for lung cancer screening

Gabriella Sozzi, Mattia Boeri

Particle therapy in non-small cell lung cancer

Zhongxing Liao, Charles B. Simone II

Computer Aided Nodule Analysis and Risk Yield (CANARY) characterization of adenocarcinoma: radiologic biopsy, risk stratification and future directions

Ryan Clay, Srinivasan Rajagopalan, Ronald Karwoski, Fabien Maldonado, Tobias Peikert, Brian Bartholmai

Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer

Neil K. Taunk, Andreas Rimner, Melissa Culligan, Joseph S. Friedberg, Julie Brahmer, Jamie Chaft

Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors

Suchit H. Patel, Andreas Rimner, Roger B. Cohen

Intraoperative near-infrared imaging of mesothelioma

Gregory Thomas Kennedy, Andrew Newton, Jarrod Predina, Sunil Singhal

BAP1, a tumor suppressor gene driving malignant mesothelioma

Mitchell Cheung, Joseph R. Testa

Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation

Jonathan E. Schoenhals, Steven N. Seyedin, Clark Anderson, Eric D. Brooks, Yun R. Li, Ahmed I. Younes, Sharareh Niknam, Ailin Li, Hampartsoum B. Barsoumian, Maria Angelica Cortez, James W. Welsh

Diagnostic and prognostic biomarkers for malignant mesothelioma: an update

Zhongjian Chen, Giovanni Gaudino, Harvey I. Pass, Michele Carbone, Haining Yang

Immunotherapy for malignant pleural mesothelioma: current status and future directions

Jordan Dozier, Hua Zheng, Prasad S. Adusumilli

Biology and clinical significance of circulating tumor cell subpopulations in lung cancer

Linda O’Flaherty, Harriet Wikman, Klaus Pantel

Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?

Emma Pailler, Vincent Faugeroux, Marianne Oulhen, Cyril Catelain, Françoise Farace

Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer

Sumitra Mohan, Francesca Chemi, Ged Brady

Biophysical technologies for understanding circulating tumor cell biology and metastasis

Derrick W. Su, Jorge Nieva

Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer

Marianna Gallo, Antonella De Luca, Monica Rosaria Maiello, Amelia D’Alessio, Claudia Esposito, Nicoletta Chicchinelli, Laura Forgione, Maria Carmela Piccirillo, Gaetano Rocco, Alessandro Morabito, Gerardo Botti, Nicola Normanno

Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer

Salma K. Jabbour, Abigail T. Berman, Charles B. Simone II

Editorial

An alternative way to initiate Notch1 signaling in non-small cell lung cancer

Yi-Lin Yang, David Jablons, Liang You

Combination MET- and EGFR-directed therapy in MET-overexpressing non-small cell lung cancers: time to move on to better biomarkers?

Fernando C. Santini, Siddharth Kunte, Alexander Drilon

Systematic Review and Meta-analysis

Association of the metformin with the risk of lung cancer: a meta-analysis

Li Wang, Yong Song, Guan-Nan Wu, Dong-Mei Yuan

China Lung Cancer Research Highlight

Dll4/Notch1 signaling from tip/stalk endothelial cell specification to stroma-dependent lung tumor inhibition: a flavor of Dll4/Notch1 pleiotropy in tumor cell biology

Maria Felice Brizzi, Paola Defilippi

Editorials

Dulanermin in cancer therapy: Still much to do

Cristina Quintavalle, Gerolama Condorelli

Review Articles

EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data

Bradley T. Clifford, Pingfu Fu, Nathan A. Pennell, Balazs Halmos, Rom S. Leidner

Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung

Pedro Mendez, Jose Luis Ramirez

Role of HGF/MET axis in resistance of lung cancer to contemporary management

Kanwal Pratap Singh Raghav, Ana Maria Gonzalez-Angulo, George R. Blumenschein Jr

Circulating soluble intercellular adhesion Molecule-1 in lung cancer: a systematic review

Xiaoling Gu, Chunyan Ma, Dongmei Yuan, Yong Song

Ceritinib

Clinical development and approval of second generation ALK inhibitors for ALK rearranged lung cancer

Daniel B. Costa

Onartuzumab plus erlotinib

Targeting MET in NSCLC: looking for a needle in a haystack

Lorenza Landi, Federico Cappuzzo

Nivolumab

Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients with advanced non-small cell lung cancer

Arun Rajan, James L. Gulley

Brief Report

The role of Imaging and Radiation Oncology Core for precision medicine era of clinical trial

Ying Xiao, Mark Rosen

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha, Hyo Sup Shim

Immunohistochemistry for predictive biomarkers in non-small cell lung cancer

Mari Mino- Kenudson

Below are the latest Translational Lung Cancer Research articles published online ahead of print publication.

Original Article

Prognostic value of ground-glass opacity on computed tomography for patients with pathological stage IA3 lung adenocarcinoma: a multicenter retrospective cohort study

Chao Chen, Shao-Jun Xu, Xiao-Qiang Du, Jia-Hua Tu, Ren-He Yan, Hui Chen, Duilio Divisi, Sang-Won Um, Yun-Fan Luo, Zhi-Fan Zhang, Cheng-Xiong You, Shao-Bin Yu, Shu-Chen Chen

Published online: 19 December 2024

Original Article

A novel bioassay reflecting response to immune checkpoint inhibitor therapy in non-small cell lung cancer with malignant pleural effusion

Ayako Takigami, Naoko Mato, Koichi Hagiwara, Makoto Maemondo

Published online: 19 December 2024

Original Article

Quantitative peripheral live single T-cell dynamic polyfunctionality profiling predicts lung cancer checkpoint immunotherapy treatment response and clinical outcomes

Zuan-Fu Lim, Xiaoliang Wu, Lin Zhu, Heidar Albandar, Maria Hafez, Chenchen Zhao, Mohammed Almubarak, Matthew Smolkin, Hong Zheng, Sijin Wen, Patrick C. Ma

Published online: 17 December 2024

Original Article

MS4A15 gene expression as a prognostic marker for clinical outcomes in lung adenocarcinoma

Lingxiao Qiu, Tingcheng Li, Bin Qing, Cailin Zhao, Xinye Zhang, Satoshi Watanabe, Armida D’Incecco, Ninh M. La-Beck, Tracy L. Leong, Chuangye Wang, Jincheng Liu, Qi Li, Li Bai, Gang Liu, Xueping Liu, Zhi Xu

Published online: 16 December 2024

Original Article

Osimertinib as a neoadjuvant therapy in resectable EGFR-mutant non-small cell lung cancer: a real-world, multicenter retrospective study

Jialong Li, Youyu Wang, Zerui Zhao, Sihua Wang, Wanpu Yan, Xiaohui Chen, Tianxiang Chen, Pengfei Li, Sheng Wang, Qiang Fang, Lin Peng, Yongtao Han, Jian Tang, Xuefeng Leng

Published online: 16 December 2024

Journal Highlight more

Translational Lung Cancer Research is an international, peer-reviewed, open-access journal indexed by Science Citation Index Expanded (SCIE) and PubMed/PubMed Central, focusing on cutting-edge development on the transition from preclinical to clinical research, including but not limited to multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer and relevant thoracic diseases.